These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4179484)

  • 21. Coagulation changes in isolated perfused lungs.
    Deysine M; Panossian A; Clarke RL; Cliffton EE; Veith FJ
    Vasc Dis; 1968 Jun; 5(2):70-7. PubMed ID: 5655303
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes in coagulation factors following acute myocardial infarction in man.
    Rennie JA; Ogston D
    Haemostasis; 1976; 5(4):258-64. PubMed ID: 1002008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 24. A COMPARISON OF BISHYDROXYCOUMARIN AND WARFARIN SODIUM IN TERMS OF COAGULATION FACTOR CHANGES AND BLEEDING COMPLICATIONS.
    FREMONT RE; WIEDMAN M; LUBELL D
    Am J Med Sci; 1963 Sep; 246():265-76. PubMed ID: 14063743
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in blood coagulation and fibrinolysis during the puerperium.
    Ygge J
    Am J Obstet Gynecol; 1969 May; 104(1):2-12. PubMed ID: 5777700
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of encortone on the coagulation and fibrinolysis system in treating some puerperal infections].
    Musiatovich Iu; Beletskiĭ M; Ezuita Ia; Rutsinskaia M
    Probl Endokrinol (Mosk); 1967; 13(2):50-3. PubMed ID: 5630147
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prolonged administration of anticoagulants after myocardial infarct].
    Asperger Z; Jursic M
    Lijec Vjesn; 1970 Mar; 92(3):369-74. PubMed ID: 4103258
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.
    Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
    Thromb Diath Haemorrh; 1972 Aug; 28(1):99-108. PubMed ID: 5074994
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma hypercoagulability after termination of oral anticoagulants.
    Harenberg J; Haas R; Zimmermann R
    Thromb Res; 1983 Mar; 29(6):627-33. PubMed ID: 6857601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term anticoagulant therapy after myocardial infarction in women.
    Borchgrevink CF; Bjerkelund C; Abrahamsen AM; Bay G; Borgen P; Grande B; Helle I; Kjörstad H; Petersen AM; Rörvik T; Thorsen R; Odegaard A
    Br Med J; 1968 Sep; 3(5618):571-4. PubMed ID: 4174488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection for anticoagulant therapy in cardiac infarction using the heparin retarded coagulation time.
    PEEL AA
    Br Heart J; 1956 Jul; 18(3):378-84. PubMed ID: 13342301
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of unsaturated fatty acids on the state of the blood coagulation and anticoagulation system in patients with coronary arteriosclerosis].
    Bobkova VI; Ezhova IS
    Kardiologiia; 1970 Oct; 10(10):26-30. PubMed ID: 5504112
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coronary thrombosis and blood coagulability with reference to the suspension of anticoagulant therapy].
    Vanacore C; Recalcati P; Sessa A
    Haematol Lat; 1968; 11(4):387-417. PubMed ID: 4186820
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of glucocorticosteroids on some coagulation tests.
    Jørgensen KA; Sørensen P; Freund L
    Acta Haematol; 1982; 68(1):39-42. PubMed ID: 6812355
    [No Abstract]   [Full Text] [Related]  

  • 36. Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy.
    Tillgren C
    Acta Med Scand; 1965 Aug; 178(2):203-19. PubMed ID: 4158084
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term anticoagulant therapy].
    Holzknecht F
    Wien Med Wochenschr; 1972 Jun; 122(23):327-34. PubMed ID: 4625299
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemostatic toxicity of Poly I-C.
    Gralnick HR; Shott LL; Zendzian RP; Homan E
    Toxicol Appl Pharmacol; 1972 May; 22(1):146-9. PubMed ID: 5034982
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical pharmacology].
    Nava Rivera A
    ADM; 1964; 21(2):125-8. PubMed ID: 4177808
    [No Abstract]   [Full Text] [Related]  

  • 40. Factor VII during warfarin treatment.
    Howarth DJ; Brozović M; Stirling Y; Reed M
    Scand J Haematol; 1974; 12(5):346-54. PubMed ID: 4859330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.